Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Vaccine crawled time : 12:00 save search
Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
EVAX | $4.2 -0.47% -0.48% 31K
|
Manufacturing
|
| O: 0.25%
H: 0.0%
C: 0.0%
evx-01 first vaccine cancer trial
Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
EVAX | $4.2 -0.47% -0.48% 31K
|
Manufacturing
|
| O: 6.58%
H: 14.71%
C: 14.12%
vaccine infection results
Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024
Published: 2024-04-01 (Crawled : 12:00) - prnewswire.com
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -1.03%
H: 0.62%
C: -3.53%
covid-19 candidate vaccine congress world
Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Published: 2024-03-27 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 2.02%
H: 1.41%
C: 0.92%
vaccine trials
Vaxart to Present at World Vaccine Congress Washington 2024 on April 3
Published: 2024-03-27 (Crawled : 12:00) - globenewswire.com
VXRT | News | $0.7652 -9.15% -10.08% 1.9M
|
Health Technology
|
| O: 0.0%
H: 7.38%
C: 5.74%
vaccine congress world
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine
Published: 2024-03-26 (Crawled : 12:00) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 1.29%
H: 0.0%
C: -3.93%
covid-19 vaccine positive trial results
Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design
Published: 2024-02-15 (Crawled : 12:00) - prnewswire.com
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: -7.32%
H: 0.0%
C: -23.98%
vaccine contract molecular
HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China
Published: 2024-01-08 (Crawled : 12:00) - globenewswire.com
HLVX | $12.29 3.63% 3.5% 280K
|
|
| O: 0.72%
H: 2.22%
C: 0.33%
candidate vaccine license norovirus agreement china
Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)
Published: 2023-11-28 (Crawled : 12:00) - globenewswire.com
EBS | $2.04 9.68% 0.49% 930K
|
Health Technology
|
| O: 2.42%
H: 1.42%
C: -5.19%
vaccine contract
Tonix Pharmaceuticals’ Vaccine Candidate, TNX-1800, Selected by NIH/NIAID Project NextGen for Inclusion in Clinical Trials
Published: 2023-11-02 (Crawled : 12:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M
|
Health Technology
|
| O: 4.1%
H: 0.0%
C: -1.96%
tnx-1800 vaccine nextgen trials
Vaxart Doses First Subject in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating Mothers
Published: 2023-11-02 (Crawled : 12:00) - globenewswire.com
VXRT | News | $0.7652 -9.15% -10.08% 1.9M
|
Health Technology
|
| O: -2.03%
H: 7.48%
C: 5.3%
candidate vaccine norovirus trial
Novavax Receives Full Marketing Authorization for Prototype COVID-19 Vaccine Nuvaxovid™ ▼ in United Kingdom
Published: 2023-10-18 (Crawled : 12:00) - prnewswire.com
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -0.78%
H: 2.5%
C: 1.09%
covid-19 vaccine prototype authorization
Vaxart to Present at World Vaccine Congress Europe 2023 on October 18-19
Published: 2023-10-11 (Crawled : 12:00) - globenewswire.com
VXRT | News | $0.7652 -9.15% -10.08% 1.9M
|
Health Technology
|
| O: 0.11%
H: 0.49%
C: -2.58%
europe vaccine congress world
Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company's Combination Vaccine Against Influenza and COVID-19
Published: 2023-10-04 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 1.48%
H: 0.2%
C: -0.33%
rna-1083 covid-19 vaccine positive influenza
Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea
Published: 2023-09-20 (Crawled : 12:00) - globenewswire.com
EVAX | $4.2 -0.47% -0.48% 31K
|
Manufacturing
|
| O: 15.19%
H: 30.22%
C: 22.99%
company vaccine mrna
Vir Biotechnology Announces First Participant Dosed in New Phase 1 Trial Evaluating VIR-1388, an Investigational T Cell Vaccine for the Prevention of HIV
Published: 2023-09-20 (Crawled : 12:00) - globenewswire.com
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: -0.3%
H: 0.61%
C: -4.58%
vir-1388 vaccine cell hiv
Evaxion expands preclinical bacterial vaccine pipeline in collaboration with leading pharmaceutical company
Published: 2023-09-18 (Crawled : 12:00) - globenewswire.com
EVAX | $4.2 -0.47% -0.48% 31K
|
Manufacturing
|
| O: -2.94%
H: 8.19%
C: -18.07%
company vaccine pipeline preclinical collaboration
IO Biotech Announces New Data Related to its IO102-IO103 Therapeutic Cancer Vaccine Presented Today at the IASLC 2023 World Conference on Lung Cancer
Published: 2023-09-12 (Crawled : 12:00) - globenewswire.com
IOBT | $1.47 0.0% 92K
|
|
| O: 1.16%
H: 2.37%
C: -14.2%
io102 lung conference biotech vaccine world cancer today
CureVac Advances Seasonal Flu Study to Phase 2 in Collaboration with GSK Following Selection of Promising mRNA Vaccine Candidate with Broad Coverage
Published: 2023-09-12 (Crawled : 12:00) - biospace.com/
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: -0.47%
H: 0.62%
C: -3.79%
candidate vaccine mrna collaboration study
Revolutionizing Vaccine Discovery: New Data Validates Evaxion AI Platform, Offering Promise to Reduce Risk and Cost in Infectious Disease Vaccine Development
Published: 2023-09-11 (Crawled : 12:00) - globenewswire.com
EVAX | $4.2 -0.47% -0.48% 31K
|
Manufacturing
|
| O: 2.71%
H: 11.6%
C: 11.6%
disease vaccine offering risk promise
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.